Target intelligence / Profile preview

Pyridoxine transporter

Molecular classification
Transporter, Solute carrier
01

Overview

Pyridoxine transporters are a specialized group of solute carrier (SLC) proteins that facilitate the movement of vitamin B6 (pyridoxine) across plasma and organellar membranes. Key human transporters include SLC19A3 (thiamine transporter 2), which mediates intestinal absorption and blood-brain barrier transport, and SLC49A4 (DIRC2), which serves as a lysosomal exporter to regulate intracellular B6 availability [1.3.2, 1.3.5]. These proteins are essential for maintaining the homeostasis of vitamin B6, a vital cofactor for over 140 enzymatic reactions, including the synthesis of neurotransmitters like GABA and serotonin [1.4.1, 1.4.5]. Clinical interest in these transporters has grown due to their role in drug-nutrient interactions, where medications such as metformin and fedratinib can inhibit transport, potentially leading to deficiency [1.2.4, 1.3.3]. Conversely, excessive pyridoxine intake or impaired transport can result in sensory peripheral neuropathy, a hallmark of B6 toxicity [1.4.4, 1.4.5]. Understanding these transporters is crucial for managing metabolic disorders, preventing drug-induced neuropathies, and optimizing vitamin supplementation therapies.

Other names
Vitamin B6 transporterSolute carrier family 19 member 3 (SLC19A3)Solute carrier family 49 member 4 (SLC49A4)Thiamine transporter 2 (THTR-2)Disrupted in renal carcinoma 2 (DIRC2)Solute carrier family 19 member 2 (SLC19A2)Thiamine transporter 1 (THTR-1)
02

Mechanism of action

Proton-coupled transport of pyridoxine vitamers across the plasma and organellar membranes.

03

Biological functions

Vitamin transportMetabolic homeostasisNeurotransmitter synthesisLysosomal exportIntestinal absorption
04

Disease associations

Vitamin B6 deficiencyPeripheral neuropathyThiamine-responsive basal ganglia disease (TRBGD)Renal cell carcinomaPyridoxine-dependent epilepsy
05

Safety considerations

Sensory peripheral neuropathyVitamin B6 deficiencyDrug-nutrient interactions
06

Interacting drugs

Metformin

6 more in the full profile.

07

Biomarkers

4-Pyridoxic acid (PDA)Pyridoxal 5'-phosphate (PLP)

Beyond the preview

Go deeper on Pyridoxine transporter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyridoxine transporter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call